Asia Pacific Prebiotics Market Revenue Analysis by Regions 2028

Asia Pacific Prebiotics Industry Overview

Asia Pacific prebiotics market size was valued at USD 1.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.6% from 2020 to 2028.

The increasing gut problems coupled with the rise in demand for preventative healthcare products in countries such as India, China, and Japan is expected to result in increased demand for prebiotics products. A large number of people suffer from digestive problems such as cramps, pain, bloating, and constipation. Moreover, certain conditions such as Gastroesophageal Reflux Disease (GERD), diverticulitis, and Irritable Bowel Syndrome (IBS) have been growing in recent years. This rising prevalence of digestive diseases has generated the demand for fiber or prebiotic-rich food and beverage products.

Gather more insights about the market drivers, restrains and growth of the Asia Pacific Prebiotics Market

China prebiotics market size, by product, 2018 - 2028 (USD Million)

The demand for inulin in China is expected to witness steady growth on account of ease of incorporation in the food & beverage industry. Inulin is used in dairy product formulations such as yogurts, cheese, and ice creams. Dairy industry growth is expected to be a key driver for the inulin market over the next few years. The technological progress in the field of functional ingredients involves heavy spending on research & development. The research & development costs can be in the form of clinical trials or research on ingredients that adhere to the food regulations in countries.

Although such factors are beneficial for well-established market players, small- and medium-sized companies find it challenging to invest heavily in R&D activities as such costs would have a bearing on the final price of functional ingredients thus posing a challenge for the market. The outbreak of animal diseases in the past has had a negative impact on the animal feed industry, thereby resulting in reduced demand for animal feed ingredients such as prebiotics. For instance, the outbreak of H5N1 bird flu severely disrupted the entire poultry industry in India and led to a significant decline in the consumption of poultry in the country.

The importance of nutritional and fortified food products rose due to the COVID-19 outbreak; thus, food manufacturers are likely to incorporate ingredients such as prebiotics into their products to increase their nutritional value in order to attract consumers. Consumers have been consuming products with functional ingredients as part of preventive health, in turn benefiting the probiotics market as well.

Browse through Grand View Research’s Nutraceuticals & Functional Foods Industry Research Reports.

  • Animal Based Protein Supplements Market: The global animal based protein supplements market size was valued at USD 12.61 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% from 2020 to 2028.
  • Nutraceuticals Market: The global nutraceuticals market size was valued at USD 454.55 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.0% from 2021 to 2030.

 

Market Share Insights

  • January 2020: Meiji Seika Pharma Co., Ltd. announced that it had entered into a distribution, and partnership agreement for the epigenetic immunomodulator, HBI-8000, from HUYA Bioscience International, LLC. 

Key Companies profiled:

Some of the prominent players in the Asia Pacific prebiotics market include:

  • BAOLINGBAO BIOLOGY
  • Tata Chemical Ltd.
  • Quantum Hi-Tech (China) Biological Co., Ltd.
  • SAMYANG HOLDINGS CORPORATION
  • CJ CheilJedang Corp
  • Meiji Holdings Co., Ltd.
  • Fuji Nihon Seito Corporation
  • Yakult Honsha Co. Ltd.

Order a free sample PDF of the Asia Pacific Prebiotics Market Intelligence Study, published by Grand View Research.

Comments are closed